Latest Neuroimaging Stories
Researchers at Penn State College of Medicine and Penn State Milton S. Hershey Medical Center (Hershey, Pennsylvania) have categorized the appearance and evolution of abnormalities on neuroimages that represent abusive head trauma (AHT) in infants.
What if experts could dig into the brain, like archaeologists, and uncover the history of past experiences?
Neuroscientists may soon be modern-day harpooners, snaring individual brain-cell signals instead of whales with tiny spears made of carbon nanotubes.
For less than $100, University of Washington researchers have designed a computer-interfaced drawing pad that helps scientists see inside the brains of children with learning disabilities while they read and write.
Researchers at the University of British Columbia have developed a new magnetic resonance imaging (MRI) technique that detects the telltale signs of multiple sclerosis in finer detail than ever before – providing a more powerful tool for evaluating new treatments.
Elena Prieto-Azkarate, a graduate in Telecommunications Engineering at the NUP/UPNA-Public University of Navarre and member of the Nuclear Medicine Service of the University College Hospital of Navarre, has implemented 12 algorithms to process medical images produced by means of PET (Positron Emission Tomography).
When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment.
For patients with advanced breast cancer, positron emission tomography (PET) and magnetic resonance (MR) imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery.
Alzheimer’s disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer’s disease—even for people with no sign of cognitive decline.
The Society of Nuclear Medicine and Molecular Imaging’s 2013 Annual Meetingmarks the unveiling of the successful application of a new preclinical hybrid molecular imaging system—single photon emission tomography and magnetic resonance (SPECT/MR)—which has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, technological advancement at a lower cost, and reduction of patient exposure to ionizing radiation.